BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30916805)

  • 21. Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia.
    Bugarin C; Sarno J; Palmi C; Savino AM; te Kronnie G; Dworzak M; Shumich A; Buldini B; Maglia O; Sala S; Bronzini I; Bourquin JP; Mejstrikova E; Hrusak O; Luria D; Basso G; Izraeli S; Biondi A; Cazzaniga G; Gaipa G;
    Haematologica; 2015 Jun; 100(6):e229-32. PubMed ID: 25862705
    [No Abstract]   [Full Text] [Related]  

  • 22. Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene.
    Chow CD; Dalla-Pozza L; Gottlieb DJ; Hertzberg MS
    Leukemia; 1999 Nov; 13(11):1893-4. PubMed ID: 10557067
    [No Abstract]   [Full Text] [Related]  

  • 23. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
    Chow YP; Alias H; Jamal R
    BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
    Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
    Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target.
    Ueno S; Lu J; He J; Li A; Zhang X; Ritz J; Silberstein LE; Chai L
    Exp Hematol; 2014 Apr; 42(4):307-316.e8. PubMed ID: 24463278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.
    Narendran A; Ganjavi H; Morson N; Connor A; Barlow JW; Keystone E; Malkin D; Freedman MH
    Exp Hematol; 2003 Aug; 31(8):693-701. PubMed ID: 12901974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
    Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
    J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia.
    Austin GE; Alvarado CS; Austin ED; Hakami N; Zhao WG; Chauvenet A; Borowitz MJ; Carroll AJ
    Am J Clin Pathol; 1998 Nov; 110(5):575-81. PubMed ID: 9802341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
    Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
    Cocco C; Airoldi I
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tisagenlecleucel (Kymriah) for ALL.
    Med Lett Drugs Ther; 2017 Oct; 59(1532):177-178. PubMed ID: 29039821
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
    Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation.
    Chen Y; Cheng Y; Suo P; Yan C; Wang Y; Chen Y; Han W; Xu L; Zhang X; Liu K; Chang L; Xiao L; Huang X
    Br J Haematol; 2017 Nov; 179(4):598-605. PubMed ID: 29076142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
    Santomasso BD; Park JH; Salloum D; Riviere I; Flynn J; Mead E; Halton E; Wang X; Senechal B; Purdon T; Cross JR; Liu H; Vachha B; Chen X; DeAngelis LM; Li D; Bernal Y; Gonen M; Wendel HG; Sadelain M; Brentjens RJ
    Cancer Discov; 2018 Aug; 8(8):958-971. PubMed ID: 29880584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
    Lei J; Li Q; Gao Y; Zhao L; Liu Y
    Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
    Tahara K; Koiso H; Osaki YH; Sekigami T; Yokohama A; Saitoh T; Tsukamoto N; Murakami H; Abe M; Handa H
    Acta Haematol; 2019; 141(3):135-137. PubMed ID: 30783036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.